M1002 structure
|
Common Name | M1002 | ||
---|---|---|---|---|
CAS Number | 823830-85-9 | Molecular Weight | 394.292 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 414.6±55.0 °C at 760 mmHg | |
Molecular Formula | C15H8F6N2O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 204.6±31.5 °C |
Use of M1002M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1]. |
Name | N-[3,5-Bis(trifluoromethyl)phenyl]-1,2-benzothiazol-3-amine 1,1-dioxide |
---|---|
Synonym | More Synonyms |
Description | M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1]. |
---|---|
Related Catalog | |
In Vitro | M1002 (10 μM; 24 h) enhances the expression of HIF-2 target genes with great efficacy[1]. M1002 (5 μM; 24 h) treatment shows synergy with prolyl hydroxylase domain (PHD) inhibitors[1]. RT-PCR[1] Cell Line: 786-O cells Concentration: 10 μM Incubation Time: 24 hours Result: Showed clear agonistic effects on the expression of HIF-2 target genes in 786-O cells as compared with the control. RT-PCR[1] Cell Line: Hep3B cells Concentration: 5 μM Incubation Time: 24 hours Result: Elevated the expression of EPO and NDRG1 by co-treatment of M1002 together with PHD inhibitors, compared with M1002 alone treatment. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 414.6±55.0 °C at 760 mmHg |
Molecular Formula | C15H8F6N2O2S |
Molecular Weight | 394.292 |
Flash Point | 204.6±31.5 °C |
Exact Mass | 394.021057 |
LogP | 5.15 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.564 |
1,2-Benzisothiazol-3-amine, N-[3,5-bis(trifluoromethyl)phenyl]-, 1,1-dioxide |
MFCD05999002 |
N-[3,5-Bis(trifluoromethyl)phenyl]-1,2-benzothiazol-3-amine 1,1-dioxide |